Eric Garshick MD
Adjunct Associate Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
72 E. Concord Street egarsh@bu.edu
eric.garshick@va.gov
Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Biography
My work has included the study of diesel exhaust and fine particle exposure and the risk of human lung cancer in large epidemiologic studies. I have studied this both in a cohort of 54,000 US railroad workers occupationally exposed as a result of working with diesel locomotives, and in a national cohort of 54,000 US trucking company workers exposed on the roadways and in trucking terminals. As well as conducting epidemiologic studies, I work closely with an exposure assessment group. This provides information regarding the determinants of exposure in the populations under study, provides information that may permit the estimation of lung cancer risk.
Websites
Education
Medicine, MD, Tufts University School of Medicine
Medicine, MOH, Harvard School of Public Health
Chemical Engineering/Biology, BS, Tufts University
Publications
Maccarone JR, Sterns OR, Timmons A, Korpak AM, Smith NL, Nakayama KS, Baird CP, Ciminera P, Kheradmand F, Fan VS, Hart JE, Koutrakis P, Jerrett M, Kuschner WG, Ioachimescu OC, Montgrain PR, Proctor SP, Redlich CA, Wendt CH, Blanc PD, Garshick E, Wan ES. Deployment-related Cigarette Smoking Behaviors and Pulmonary Function Among U.S. Veterans. Mil Med. 2024 Mar 25. PMID: 38536226.
Published on 3/22/2024Zhang CL, Maccarone JR, Grady ST, Collins CM, Moy ML, Hart JE, Kang CM, Coull BA, Schwartz JD, Koutrakis P, Garshick E. Indoor and ambient black carbon and fine particulate matter associations with blood biomarkers in COPD patients. Sci Total Environ. 2024 Mar 22; 927:171897. PMID: 38522542.
Published on 2/2/2024Garshick E, Redlich CA, Korpak A, Timmons AK, Smith NL, Nakayama K, Baird CP, Ciminera P, Kheradmand F, Fan VS, Hart JE, Koutrakis P, Kuschner W, Ioachimescu O, Jerrett M, Montgrain PR, Proctor SP, Wan ES, Wendt CH, Wongtrakool C, Blanc PD. Chronic respiratory symptoms following deployment-related occupational and environmental exposures among US veterans. Occup Environ Med. 2024 Feb 02; 81(2):59-65. PMID: 37968126.
Published on 10/27/2023Romero-Gutierrez C, Koutrakis P, Liu M, Zilli Vieira CL, Coull BA, Maher EF, Zhang JJ, Garshick E. Radon decay product particle radioactivity and oxidative stress biomarkers in patients with COPD. Environ Res. 2024 Jan 01; 240(Pt 2):117505. PMID: 37890828.
Published on 10/15/2023Li L, Stern RA, Garshick E, Zilli Vieira CL, Coull B, Koutrakis P. Predicting Monthly Community-Level Radon Concentrations with Spatial Random Forest in the Northeastern and Midwestern United States. Environ Sci Technol. 2023 Nov 21; 57(46):18001-18012. PMID: 37839072.
Published on 10/5/2023McHugh EG, Grady ST, Collins CM, Moy ML, Hart JE, Coull BA, Schwartz JD, Koutrakis P, Zhang J, Garshick E. Pulmonary, inflammatory, and oxidative effects of indoor nitrogen dioxide in patients with COPD. Environ Epidemiol. 2023 Oct; 7(5):e271. PMID: 37840862.
Published on 7/5/2023Maccarone J, Grady ST, Moy ML, Hart JE, Kang CM, Coull BA, Schwartz JD, Koutrakis P, Zhang J, Garshick E. Indoor (residential) and ambient particulate matter associations with urinary oxidative stress biomarkers in a COPD cohort. Sci Total Environ. 2023 Nov 01; 897:165352. PMID: 37419349.
Published on 6/27/2023Ross JM, Sugimoto JD, Timmons A, Adams J, Deardoff K, Korpak A, Liu C, Moore K, Wilson D, Bedimo R, Chang KM, Cho K, Crothers K, Garshick E, Gaziano JM, Holodniy M, Hunt CM, Isaacs SN, Le E, Jones BE, Shah JA, Smith NL, Lee JS. Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans. Open Forum Infect Dis. 2023 Jul; 10(7):ofad330. PMID: 37484899.
Published on 3/24/2023Zilli Vieira CL, Koutrakis P, Liu M, Gottlieb DJ, Garshick E. Intense solar activity reduces urinary 6-sulfatoxymelatonin in patients with COPD. Respir Res. 2023 Mar 24; 24(1):91. PMID: 36959654.
Published on 3/24/2023Zilli Vieira CL, Koutrakis P, Liu M, Gottlieb DJ, Garshick E. Intense solar activity reduces urinary 6-sulfatoxymelatonin in patients with COPD. Respir Res. 2023 Mar 24; 24(1):91. PMID: 36959654.